Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Deglutition Disorders × epigallocatechin gallate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leiomyoma 2 Papillomavirus Infections 1 Low-Grade Intraepithelial Neoplasia of Cervix 1 Liver Neoplasms 1 Liver Cirrhosis 1 Inflammation 1 Frailty 1 Esophageal Neoplasms 1 Deglutition Disorders 1 Carcinoma, Hepatocellular 1

Interventions

epigallocatechin gallate 1 Tablets 1 Standard of Care 1 Pravastatin 1 Cryotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06398405 2024-05-03

A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer

Shandong Cancer Hospital and Institute

Phase 2 Recruiting

Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡